China's Ongoing 'COVID Zero' Policies To Prompt More Domestic Deals?
Executive Summary
China biotechs appear increasingly interested in partnering with domestic counterparts amid signs the Chinese government's restrictive "COVID Zero" policies are likely to stay until well into 2023.